Introduction {#s1}
============

Application of probiotics is one of current approaches for biocontrol and growth promotion in aquaculture (Balcázar et al., [@B5]). Many different types of bacteria including lactic acid bacteria (LAB) are used as probiotics in fish. In particular, LAB can enhance fish survival by exerting metabolic effects at many levels because LAB can deal with low pH condition and bile acids toxicity presented throughout the gut (Corcoran et al., [@B11]; Martin et al., [@B43]). Recent studies have indicated that the use of host-derived probiotics can offer significant advantages in terms of survival and beneficial functions because their physiological activities are at optimum level in the same natural habitats (Lazado et al., [@B36]; Safari et al., [@B63]). Improved growth performance and decreased infection rate have been observed in olive flounder (*Paralichthys olivaceus*) fed with a host-derived LAB probiotic strain, *Lactococcus lactis* WFLU12 (Nguyen et al., [@B52]). Our recent study (Nguyen and Kim, [@B51]) has demonstrated that strain WFLU12 harbors genes supporting probiotic action based on genome-wide comparison of different *L. lactis* strains.

The growth of animals involves complex processes of protein synthesis and breakdown (Doherty and Whitfield, [@B18]). The intestine is an important site for the metabolism of dietary nutrients including high levels of protein and amino acids. These nutrients have to traverse intestinal mucosal epithelial cells before entering the bloodstream and body tissues. Metabolome is defined as biochemical compositions of small--molecule metabolites of amino acids, fatty acids, carbohydrates, vitamins, and lipids involved in metabolism. These small-molecule metabolites are required for the maintenance, growth, and normal function of cells (Harrigan and Goodacre, [@B25]). Metabolome analysis allows us to figure out biochemical reactions being catalyzed by proteins of the proteome which in turn can help us determine biological structure and function of the final phenotype of an organism. In addition, analysis of metabolites produced by intestinal microbiota is an ideal approach to assess health status of the host (Matsumoto et al., [@B46]). In fish, intestinal bacteria or probiotics possibly produce various kinds of enzymes such as cellulase, amylase, lipase, protease, and chitinase for digestion (Bairagi et al., [@B4]). They can also regulate the synthesis of specific essential nutrients such as amino acids, fatty acids, and vitamins for fish (Nayak, [@B50]; Semova et al., [@B67]). To the best of our knowledge, modes of actions of dietary probiotics used as supplement for fish growth have not been assessed, although large-scale metabolome analysis is rapidly evolving in recent years (Ohashi et al., [@B54]; Wikoff et al., [@B80]).

The objective of the present study was to clarify the mode of action involved in the growth promotion effect of probiotics administration in fish. Low-molecular-weight metabolites in samples obtained from healthy fish fed with or without probiotic strain WFLU12 were analyzed and expression levels of metabolites between the two groups were compared to determine changes in the probiotic-fed group. We also attempted to evaluate the benefit of dietary probiotics for host physiology through systemic circulation metabolome analysis. In addition, the whole genome of strain WFLU12 was analyzed to determine any potential genes involved in fish metabolism to increase metabolites.

Materials and methods {#s2}
=====================

Ethics approval
---------------

Animal experiments performed in this study did not involve any endangered or protected species. All animal experiments were approved by the Animal Ethics Committee of Pukyong National University (Busan, Korea). These experiments were conducted under the guidelines of Animal Ethics Committee Regulations, No. 554 issued by Pukyong National University, Busan, Republic of Korea.

Animals and probiotic administration
------------------------------------

Olive flounder (\~165 g and \~26 cm fish^−1^) were purchased from a commercial fish farm in Korea and acclimatized to conditions of aerated and circulated fresh sea water under a 12:12 h light:dark photoperiod for several weeks. After acclimation, fish were randomly divided into a control group and a probiotic-treated group. Control fish were fed a commercial diet (DongA One Corporation, Korea) consisting of crude protein (52%), crude ash (15%), crude fat (10%), phosphorus (2.7%), crude fiber (2%), and calcium (1.2%), while the experimental group of fish were fed a probiotic-supplemented diet (strain WFLU12 at 10^9^ CFU g^−1^ of commercial feed). Strain WFLU12 originally isolated from gastrointestinal tract of wild olive flounder has already been characterized biochemically and genomically in our previous studies (Nguyen et al., [@B52]; Nguyen and Kim, [@B51]). Both groups (*n* = 48 for each) were fed at a rate of 3% biomass per day with two daily feedings (9 a.m. and 5 p.m.) for 16 weeks. Weight and length of all the fish in each group were measured every two weeks as described previously (Nguyen et al., [@B52]). After obtaining growth rate and weight, the ration was adjusted accordingly for the next feeding period. At week 16, nine fish were randomly selected from each group to obtain serum and intestinal mucus samples to obtain three pooled serum and mucus samples for each group. All samples were subjected to analyses of ionic metabolites by CE-TOFMS.

CE-TOFMS
--------

Metabolomics measurements were performed using an Agilent CE-TOFMS system (Agilent Technologies Inc.). Data were processed with Human Metabolome Technologies Inc. (Tsuruoka, Japan). Values of peaks were normalized to those of methionine sulfone (cationic internal standard) and D-camphor-10-sulfonic acid (anionic internal standard). Detailed information of specimen preparation and CE-TOFMS analysis used in this study is shown in Supplementary Material.

Ratio of metabolite concentration (probiotics: control group)
-------------------------------------------------------------

In this study, we classified metabolites according to the ratio of values in probiotic-fed group to those in the control group (Pro/Con ratio) as described previously (Matsumoto et al., [@B47]). We defined threshold Pro/Con ratio to determine whether metabolites were present at higher or lower concentrations in probiotic-fed fish than those in control fish. In this study, the highest Pro/Con ratio for metabolites present at higher concentrations in fish fed with probiotics than those in control fish (the difference was significantly different) was 1.202 (Additional File [3](#SM14){ref-type="supplementary-material"}). The lowest Pro/Con ratio for metabolites present at lower concentrations in fish fed with probiotics than those in control fish was 0.830 (Table [S1](#SM9){ref-type="supplementary-material"}). Therefore, the Pro/Con ratio of metabolites present at higher concentrations in fish fed with probiotics than those in control fish was defined at ≥ 1.20 and the Pro/Con ratio of metabolites present at lower concentrations in fish fed with probiotics than those in control fish was defined at \<0.8.

Prediction of genes of strain WFLU12 involved in increase of metabolites
------------------------------------------------------------------------

To find genes of probiotic strain WFLU12 potentially involved in significant increase of metabolites in olive flounder, its whole genome sequence (Accession no. [PKRZ00000000](PKRZ00000000)) (Nguyen and Kim, [@B51]) was exploited using KEGG analysis (Moriya et al., [@B48]).

Data analysis and statistics
----------------------------

Putative metabolites were assigned from HMT\'s standard compound library and Known-Unknown peak library based on m/z and MT. If several peaks were assigned to the same candidate, the candidate was given a branch number. Hierarchical cluster analysis (HCA) was performed with PeakStat ver. 3.18 (HMT\'s in-house software). Principal component analysis (PCA) was performed using SampleStat ver. 3.14 (HMT\'s in-house software). Differences in relative quantity of individual metabolites between probiotic-fed fish and control fish were evaluated by Welch\'s *t*-test. The ratio between the two was computed using averaged detection values. Differences in level distribution of whole metabolites between control and probiotic groups were compared using Wilcoxon--Mann--Whitney test. Statistical significance was considered at *p* \< 0.05.

Results {#s3}
=======

Viability of probiotic cells in fish gut
----------------------------------------

Total bacterial counts grown on marine agar for gut mucus retrieved from control and probiotic-fed groups were 5.16 ± 0.72 and 4.79 ± 0.68 log CFU g^−1^ gut mucus, respectively, showing no significant difference between the two groups. Bacterial counts of *L. lactis* (confirmed by PCR) grown on MRS agar recovered from gut mucus of fish in the probiotic-fed group were found to be 4.65 ± 0.61 log CFU g^−1^. However, no LAB was found in gut mucus of fish from the control group.

Growth measurements
-------------------

Olive flounder were fed with or without probiotic-containing diet and their growths were monitored for 16 weeks. At the end of the experiment, mean weight and length were 329.98 (g) and 30.77 (cm), respectively, in the probiotic-fed group and 301.06 (g) and 29.60 (cm), respectively, in the control group (Figures [1A,B](#F1){ref-type="fig"}), showing significant differences between the two groups. Specific growth rate (SGR) and feed efficiency (FE) in the probiotic-fed group were 0.61 ± 0.18 and 0.72 ± 0.25, respectively, which were significantly higher than those (0.26 ± 0.12 and 0.30 ± 0.12, respectively) in the control group (Figures [1C,D](#F1){ref-type="fig"}).

![Growth performance of olive flounder (*n* = 48 for each group) fed with or without probiotic *L. lactis* WFLU12 (10^9^ CFU/g of feed) supplemented diets. Weight gain **(A)**, length gain **(B)**, feed efficiency **(C)**, and specific growth rate **(D)** of olive flounder were measured during the experiment period. Each bar represents mean value with standard error (SE). \**p* \< 0.05 compared to the control.](fmicb-09-02059-g0001){#F1}

Differences in intestinal and serum metabolome between the two dietary groups
-----------------------------------------------------------------------------

CE-TOFMS analyses of compounds present in the prepared pellet (including probiotic-mixed diets-Pellet-P and control diets-Pellet-C) showed 240 compounds, including 148 compounds in cation mode and 92 compounds in anion mode (Additional File [1](#SM12){ref-type="supplementary-material"}). Levels of compounds between Pellet-P and Pellet-C were not significantly different (*p* \> 0.05 based on Wilcoxon--Mann--Whitney test), indicating that these experimental diets equally distributed compounds to fish in both groups.

A total of 200 metabolites (110 cations and 90 anions) were identified from intestinal mucus samples by CE-TOFMS. Patterns of these metabolites from individual samples were subjected to hierarchical clustering and principal component analysis (PCA) as shown in Figure [2](#F2){ref-type="fig"}. Conspicuously, the intestinal metabolome displayed remarkable difference between the control and probiotic-fed fish groups (Figure [2C](#F2){ref-type="fig"}), showing that probiotic supplementation significantly modified intestinal metabolome of the host. Of these 200 metabolites, 147 metabolites showed no difference in concentration between the two groups (labeled as IFP ≈ IFC; Additional file [2](#SM13){ref-type="supplementary-material"}). However, concentrations of 53 metabolites were significantly (*p* \< 0.05) higher or at least 1.5-fold higher (*p* \< 0.1) in the probiotic-fed fish group compared to those in the control group (labeled as IFP \> IFC) (Figure [2D](#F2){ref-type="fig"} and Additional file [3](#SM14){ref-type="supplementary-material"}).

![Difference in intestinal metabolome between control fish and probiotic-fed fish. **(A)** Hierarchical clustering showing patterns of intestinal metabolites. Red and green indicate high and low concentrations of metabolites, respectively. **(B)** PCA profiling of data from intestinal metabolome. **(C)** Phylogenetic tree displaying dissimilarity between control and probiotic-fed groups. **(D)** The number of intestinal metabolites in groups IFP \> IFC, IFP ≈ IFC, and IFP \< IFC.](fmicb-09-02059-g0002){#F2}

A total of 171 metabolites (103 cations and 68 anions) were identified from serum samples from the two fish groups. PCA scores from plot and hierarchical clustering analysis showed that patterns of metabolites in the serum or the degree of clustering did not clearly show distint difference between the two groups (Figure [3](#F3){ref-type="fig"}). This indicates that probiotic treatment with strain WFLU12 did not significantly change serum metabolic profiles on fish. Mean values of five metabolites (carboxymethyllysine, citrulline, mannosamine, cystathionine, and caffeine) in the probiotic-fed fish group were significantly higher (*p* \< 0.05) than those in the control group (denoted as SerP \> SerC). However, six metabolites (glucuronic acid-1 or galacturonic acid-1, N,N-Dimethylglycine, prostaglandin F2α, phosphoenolpyruvic acid, homocarnosine, and γ-Glu-2-aminobutyric acid) in the serum were decreased markedly or at least 1.5-fold lower (*p* \< 0.1) in the probiotic-fed group than those in the control group (denoted as SerP \< SerC) (Table [S1](#SM9){ref-type="supplementary-material"}). Probiotic-fed fish also showed a tendency to have higher (*p* \< 0.1) levels or unique detection of the following metabolites: 5-hydroxylysine, allantoic acid, acetoacetic acid, formiminoglutamic acid, Gln, tyrosine methyl ester, and penicillamine (Additional File [4](#SM15){ref-type="supplementary-material"}).

![Difference in serum metabolome between control fish and probiotic-fed fish. **(A)** Hierarchical clustering showing patterns of serum metabolites. Red and green indicate high and low concentrations of metabolites, respectively. **(B)** PCA profiling of data from serum metabolome. **(C)** Phylogenetic tree displaying dissimilarity between control and probiotic-fed samples. **(D)** The number of serum metabolites in groups SerP \> SerC, SerP ≈ SerC, and SerP \< SerC.](fmicb-09-02059-g0003){#F3}

Classification of metabolites
-----------------------------

To determine whether the probiotic supplement could help fish enhance feed conversion or maintain host physiology, we classified intestinal metabolites by comparing pellet compounds and serum metabolites. We then evaluated the influence of the supplemented probiotic on serum metabolome. Metabolites and/or compounds detected from the intestine and pellet were devived into five different groups: (a) metabolites belonging to group IFP \> IFC but not detected from the pellet, (b) metabolites or compounds belonging to group IFP \> IFC and detected from the pellet, (c) metabolites belonging to group IFP ≈ IFC but not detected from the pellet, (d) metabolites or compounds belonging to group IFP ≈ IFC and detected from the pellet, and (e) compounds only detected from the pellet (Figure [4A](#F4){ref-type="fig"}, Additional File [5](#SM16){ref-type="supplementary-material"}). Of these metabolite and/or compound groups, this study focuses on groups a and b as they were likely to be invovled in changes in the metabolic processes in fish. Thus, these identified metabolites were classified into 10 functional groups (highlighted in Figure [S1](#SM1){ref-type="supplementary-material"} and Additional File [3](#SM14){ref-type="supplementary-material"}). In detail, nine metabolites belonging to group a might be produced by host/intestinal microbiota and enriched by the presence of probiotic bacteria in the intestine, while the 44 metabolites belonging to group b were those derived from the pellet and uplifted under the abundant survival of probiotic cells. In particular, amino acid derivatives (10 metabolites), central carbon metabolism intermediates (9 metabolites), and lipid metabolism relatives (8 metabolites) were found to be dominant in group IFP \> IFC.

![Venn diagram of metabolites and/or compounds noted in the pellet, intestine, and serum metabolome. **(A)** Classification of metabolites and/or compounds detected from fish intestine and pellets (five different groups). **(B)** Classification of metabolites detected from serum and intestine (see additional files and text for details).](fmicb-09-02059-g0004){#F4}

Classification analysis of metabolites detected from fish intestine and serum revealed that 122 (71.3%) of 171 serum metabolites overlapped with intestinal metabolites (Figure [4B](#F4){ref-type="fig"}), suggesting that they might have been absorbed in the gut and conveyed to the body. A total of 78 metabolites were present only in the intestine profile. They might not have been transported to the body due to filtration by the intestinal wall and/or they are metabolized in internal organs before systemic circulation. The first chemical alteration (metabolization and/or bio-transformation) of many compounds can occur in the colonocyte and the liver (via portal vein) (Matsumoto et al., [@B47]). A total of 49 (28.7%) metabolites were detected only in the serum, implying that these metabolites might have been derived from metabolism in organs such as kidney, muscle, and liver (Wikoff et al., [@B80]; Torell et al., [@B75]). These metabolites detected in this study can be divided into three categories as shown in the Venn diagram (Figure [4B](#F4){ref-type="fig"}): (1) metabolites (similar pro/con ratios between the intestine and serum) that can be transported from the intestinal lumen to the systemic circulation independent of gateways (category i); (2) metabolites (different pro/con ratios between the intestine and serum) that are influenced by gateways such as the membrane transport system of enterocytes and/or metabolism during transcellular transport (category ii); and (3) metabolites that are not transported to the body or consumed by internal organs(category (iii). Of 122 metabolites (Table [S2](#SM10){ref-type="supplementary-material"}), 45 (No. 1 to No. 45) belonged to category i. They do not appear to be affected by any gateways. The remaining 77 metabolites (No. 46 to No. 122) belonged to category ii. They might be influenced by gateways.

Increased metabolites and weight gain
-------------------------------------

Most metabolites (187 out of 200 in the intestine, and 114 out of 171 metabolites in the serum) detected in probiotic-fed fish had higher concentrations than these in the control (Figure [S2](#SM2){ref-type="supplementary-material"}). A right-skewed distribution of intestinal metabolite level was particularly indicated in the probiotic-fed group compared to that in the control group (Wilcoxon-Mann-Whitney test: *p* = 0.035 with test variant H1:a_con \< b_pro). However, no significant differences in metabolite level was observed for the 171 metabolites detected from fish serum between the two groups. Relative quantities of annotated intestinal metabolites in principal metabolic pathways are represented as bar graphs as shown in Figure [5](#F5){ref-type="fig"}. Concentrations of metabolites involved in pathways of lipid and amino acid metabolism, polyamine, nucleotide metabolism, and central carbon metabolism were significantly higher in the probiotic-fed group than those in the control group (Table [1](#T1){ref-type="table"}). Principal metabolic pathways of serum metabolites are depicted in Figure [S3](#SM3){ref-type="supplementary-material"}.

![Differences of intestinal metabolites between control fish and probiotic-fed fish on systemic metabolic pathways. Relative quantities of annotated metabolites are represented as bar graphs (blue, control; red, probiotic). Metabolites surrounded by red circles are of higher concentrations in the probiotic group than those in the control group. ND, not detected.](fmicb-09-02059-g0005){#F5}

###### 

Significantly increased metabolites detected in probiotic-fed fish and their functions.

                                                    **Compound name**                       **IFP/IFC**   **SerP/SerC**   **Function**                                                                                                                   **References**.
  ------------------------------------------------- --------------------------------------- ------------- --------------- ------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------
  **POLYAMINE AND NUCLEOTIDE METABOLISM**                                                                                                                                                                                                                
  Polyamines                                        N^8^-Acetylspermidine                   1.88          ND              A reservoir for spermidine; intestinal maturation                                                                              Péres et al., [@B58]
  Nucleotide metabolism                             AMP                                     1.29          ND                                                                                                                                             
                                                    Guanosine                               1.49          1.25                                                                                                                                           
                                                    Hypoxanthine                            1.20          0.94                                                                                                                                           
                                                    Inosine                                 1.65          2.34            Enhanced growth performance, survival, feed utilization, immune response, hematological parameters and intestinal morphology   Burrells et al., [@B9]; Song et al., [@B72]; Peng et al., [@B57]
  **LIPID AND AMINO ACID METABOLISM**                                                                                                                                                                                                                    
  Sulfur amino acid metabolism                      Taurine                                 1.28          1.03            Enhance growth; Osmotic pressure regulation; Gut development                                                                   Salze and Davis, [@B65]
                                                    Cysteinesulfinic acid                   3.13          ND              Taurine function                                                                                                               
                                                    Cysteic acid                            2.07          ND              Taurine function                                                                                                               
                                                    Homocysteic acid                        1.97          ND                                                                                                                                             
  Carnitine metabolism                              γ-Butyrobetaine                         1.90          1.36                                                                                                                                           
                                                    Carnitine                               1.48          0.98            Fat digestibility                                                                                                              Xie et al., [@B82]
                                                    Butyrylcarnitine                        1\<           0.74                                                                                                                                           
                                                    5-Hydroxylysine                         1.94          1.31            Collagen function                                                                                                              Li et al., [@B39]
  Choline metabolism                                Phosphorylcholine                       1.48          1.31            Structure in membrane; neurotransmitter;                                                                                       Xie et al., [@B82]
                                                    Betaine                                 1.79          1.26            Intestinal health                                                                                                              Li et al., [@B39]; Xie et al., [@B82]
                                                    Betaine aldehyde\_+H~2~O                1.80          ND                                                                                                                                             
  Urea cycle and metabolism of Glu, Gln, His, Pro   1-Methyl-4-imidazoleacetic acid         1.91          1.37                                                                                                                                           
                                                    Hydroxyproline                          1.81          0.99            Enhance growth; Collagen function                                                                                              Li et al., [@B39]; Xie et al., [@B82]
                                                    Citrulline                              1.64          2.04            Arginine function                                                                                                              Dhanakoti et al., [@B17]; Curis et al., [@B13]
                                                    Homocitrulline                          1\<           1.04                                                                                                                                           
                                                    Allantoic acid                          1.79          1.20                                                                                                                                           
                                                    Glutathione (GSSG)\_divalent            1.50          1.31            Antioxidant and cell signaling                                                                                                 Li et al., [@B39]
                                                    N-Acetylglutamic acid                   2.06          ND                                                                                                                                             
  Creatine metabolism                               Creatine                                1.44          1.04            High energy storage; antioxidant; Potential to increase muscle mass                                                            Andersen et al., [@B3]
  **CENTRAL CARBON METABOLISM AND TCA CYCLE**                                                                                                                                                                                                            
  TCA                                               Citric acid                             1\<           1.17            Improve fish growth, nutrient utilization, and disease resistance                                                              Pan et al., [@B55]; Sarker et al., [@B66]
                                                    Fumaric acid                            1.45          0.77                                                                                                                                           
                                                    Malic acid                              1.55          0.72                                                                                                                                           
                                                    Succinic acid                           1.51          0.70                                                                                                                                           
  Amino sugar                                       N-Acetylglucosamine 1-phosphate         1.51          ND                                                                                                                                             
                                                    N-Acetylneuraminic acid                 1.58          1.07                                                                                                                                           
  Nucleotide sugar                                  Glucose 1-phosphate                     1.83          ND                                                                                                                                             
  Glycolysis/Glyconeogenesis                        Glycerol 3-phosphate                    1.51          0.81                                                                                                                                           
  Keton body                                        3-Hydroxybutyric acid                   1.59          1.10            Storage compound of SCFA; Intestine health;                                                                                    García Martín et al., [@B23]; Yagci et al., [@B83]; den Besten et al., [@B16]
  **METABOLISM OF COENZYMES**                                                                                                                                                                                                                            
  Vitamin C metabolism                              Ascorbic acid                           1.89          ND              Increase the hydroxyproline; improve the growth performance and feed utilization                                               Fournier et al., [@B21]; Li et al., [@B39]; Kim and Kang, [@B32]
  Riboflavin metabolism                             FAD_divalent                            1.42          ND              Energy metabolism of carbohydrates, fats, and proteins                                                                         Shiau and Lin, [@B68]; LeBlanc et al., [@B37]
  Nicotinamide metabolism                           Nicotinamide                            1.43          0.95                                                                                                                                           
  Thiamine metabolism                               Thiamine                                1.69          1.18                                                                                                                                           
  **OTHERS**                                                                                                                                                                                                                                             
                                                    Carboxymethyllysine                     1.53          1.29                                                                                                                                           
                                                    5-Aminovaleric acid                     1.79          ND                                                                                                                                             
                                                    Methionine sulfoxide                    1.69          1.30                                                                                                                                           
                                                    N-Acetylaspartic acid                   1.93          1.03                                                                                                                                           
                                                    Glucaric acid                           1.66          1.25                                                                                                                                           
                                                    Gluconic acid                           1.64          1.12                                                                                                                                           
                                                    Glucuronic acid-1 Galacturonic acid-1   1.49          0.83                                                                                                                                           
                                                    Glutaric acid                           1.29          0.82                                                                                                                                           
                                                    Anserine_divalent                       1.65          0.91                                                                                                                                           
                                                    Cysteine glutathione disulfide          1.51          1.04                                                                                                                                           
                                                    2-(Creatinine-3-yl)propionic acid       1.84          ND                                                                                                                                             
                                                    2-Hydroxy-4-methylvaleric acid          1.63          1.36                                                                                                                                           
                                                    4-(β-Acetylaminoethyl)imidazole         2.29          1.59                                                                                                                                           
                                                    Threonic acid                           1.99          1.13                                                                                                                                           
                                                    XA0004                                  1.82          1.07                                                                                                                                           
                                                    XA0033                                  1.46          1.30                                                                                                                                           

1\<, only detected in probiotic group

*N.D. (Not Detected): Target peak or metabolite was below detection limits*.

Genes of *L. lactis* WFLU12 involved in increase of metabolites
---------------------------------------------------------------

In the present study, 79 genes of *L. lactis* WFLU12 were found to be involved in 53 increased metabolites in the probiotic-fed group (Table [2](#T2){ref-type="table"}). Functions of these genes included energy metabolism and nutrient absorption (e.g., vitamins, TCA cycle intermediates, taurine, and 3-hydroxybutyric acid), gut development (e.g., taurine, citrulline, and polyamines), and regulation of growth and development (e.g., citrulline, hydroxyproline, taurine). A better understanding for functions of genes involved in fish growth is needed because some metabolism pathways are found to be limited or even completely absent in fish due to the lack of host enzymes (for example, limited de novo synthesis of arginine in fish (Li et al., [@B39]), lack of nucleotides de novo synthesis in intestinal cells (Quan, [@B59]), and weak capacity of taurine biosynthesis in olive flounder (Wang et al., [@B79]).

###### 

Genes of *L. lactis* WFLU12 potentially involved in increased metabolites.

  **Metabolite**                    **Gene description**                                                                                        **EC number**               **Gene name**   **Locus tag**   **Gene type\#**
  --------------------------------- ----------------------------------------------------------------------------------------------------------- --------------------------- --------------- --------------- -----------------
  2-Hydroxy-4-methylvaleric acid    L-2-hydroxyisocaproate dehydrogenase                                                                        1.1.1.-                                     Prokka_01454    Dispensable
  3-Hydroxybutyric acid             3-hydroxyisobutyrate dehydrogenase                                                                          EC 1.1.1.31                 mmsB            Prokka_00965    Dispensable
  3-Hydroxybutyric acid             3-ketoacyl-CoA thiolase (EC 2.3.1.16) @ Acetyl-CoA acetyltransferase (EC 2.3.1.9)                           EC 2.3.1.16 EC 2.3.1.9      atoB_1          Prokka_02419    Core
  3-Hydroxybutyric acid             3-ketoacyl-CoA thiolase (EC 2.3.1.16) @ Acetyl-CoA acetyltransferase (EC 2.3.1.9)                           EC 2.3.1.16 EC 2.3.1.9      atoB_2          Prokka_00418    Dispensable
  AMP                               Adenine phosphoribosyltransferase                                                                           EC 2.4.2.7                  apt             Prokka_01595    Core
  AMP                               Adenylosuccinate lyase                                                                                      EC 4.3.2.2                  purB            Prokka_00224    Core
  AMP, thiamine                     Adenylate kinase                                                                                            EC 2.7.4.3                  adk             Prokka_00825    Core
  Ascorbic acid                     PTS system, ascorbate-specific IIC component                                                                EC:2.7.1.194                ulaC            Prokka_00208    Dispensable
  Ascorbic acid                     PTS system, ascorbate-specific IIA component                                                                                            ulaA            Prokka_00206    Dispensable
  Carboxymethyllysine               N5-(carboxyethyl)ornithine synthase                                                                         EC:1.5.1.24                 ceo             Prokka_01676    Core
  Citric acid                       Aconitate hydratase                                                                                         EC 4.2.1.3                  acnA            Prokka_01615    Core
  Citric acid                       Citrate synthase (si)                                                                                       EC 2.3.3.1                  gltA            Prokka_01614    Core
  Citrulline                        Acetylglutamate kinase                                                                                      EC:2.7.2.8                  argB            Prokka_01842    Core
  Citrulline                        Acetylornithine deacetylase                                                                                 EC:3.5.1.16                 argE            Prokka_01527    Core
  Citrulline                        Acetylornithine/N-succinyldiaminopimelate aminotransferase                                                  EC:2.6.1.11 2.6.1.17        argD            Prokka_01841    Dispensable
  Citrulline                        Alanine-synthesizing transaminase                                                                           EC:2.6.1.66 2.6.1.2         alaA            Prokka_01171    Core
  Citrulline                        Arginine deiminase                                                                                          EC:3.5.3.6                  arcA            Prokka_00791    Core
  Citrulline                        Argininosuccinate lyase                                                                                     EC:4.3.2.1                  argH            Prokka_01135    Core
  Citrulline                        Carbamate kinase                                                                                            EC:2.7.2.2                  arcC            Prokka_00276    Core
  Citrulline                        Carbamate kinase                                                                                            EC:2.7.2.3                  arcC            Prokka_00787    Core
  Citrulline                        Carbamate kinase                                                                                            EC:2.7.2.4                  arcC            Prokka_00788    Core
  Citrulline                        Carbamoyl-phosphate synthase large subunit                                                                  EC:6.3.5.5                  carB            Prokka_00118    Core
  Citrulline                        Carbamoyl-phosphate synthase small subunit                                                                  EC:6.3.5.5                  carA            Prokka_00181    Core
  Citrulline                        Glutamate N-acetyltransferase / amino-acid N-acetyltransferase                                              EC:2.3.1.35 EC:2.3.1.1      argJ            Prokka_01840    Dispensable
  Citrulline                        Glutamine synthetase                                                                                        EC:6.3.1.2                  glnA            Prokka_00951    Dispensable
  Citrulline                        N-acetyl-gamma-glutamyl-phosphate reductase                                                                 EC:1.2.1.38                 argC            Prokka_01839    Core
  Citrulline                        Argininosuccinate synthase                                                                                  EC:6.3.4.5                  argG            Prokka_01134    Core
  Citrulline                        Ornithine carbamoyltransferase                                                                              EC:2.1.3.3                  argF            Prokka_00790    Core
  Citrulline                        Ornithine carbamoyltransferase                                                                              EC:2.1.3.4                  argF            Prokka_01843    Core
  Cysteic acid                      L-serine dehydratase                                                                                        EC:4.3.1.17                 sdaA            Prokka_01865    Core
  Cysteic acid                      L-serine dehydratase                                                                                        EC:4.3.1.18                 sdaB            Prokka_01866    Core
  Cysteic acid                      Phosphoadenosine phosphosulfate reductase                                                                   EC:1.8.4.8                  cysH            Prokka_02147    Dispensable
  Cysteic acid                      Phosphoadenosine phosphosulfate reductase                                                                   EC:1.8.4.8                  cysH            Prokka_02536    Dispensable
  Cysteic acid                      Sulfite exporter TauE/SafE                                                                                                                              Prokka_00969    Dispensable
  Cysteic acid                      Aspartate aminotransferase                                                                                  EC 2.6.1.1                  aspB            Prokka_00474    Core
  Cysteine desulfurase              Cysteine desulfurase                                                                                        EC:2.8.1.7                  iscS            Prokka_00504    Core
  Cysteine desulfurase              Cysteine desulfurase                                                                                        EC:2.8.1.8                  iscS            Prokka_01482    Core
  FAD_divalent                      5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase                                                      EC:3.1.3.104                ycsE            Prokka_00365    Core
  FAD_divalent                      6,7-dimethyl-8-ribityllumazine synthase                                                                     EC:2.5.1.78                 ribH            Prokka_02055    Core
  FAD_divalent                      Diaminohydroxyphosphoribosylaminopyrimidine deaminase / 5-amino-6-(5-phosphoribosylamino)uracil reductase   EC:3.5.4.26 EC:1.1.1.193    ribD            Prokka_02052    Core
  FAD_divalent                      FMN hydrolase / 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase                                      EC:3.1.3.102 EC:3.1.3.104   ybjI            Prokka_00055    Dispensable
  FAD_divalent                      Riboflavin kinase / FMN adenylyltransferase                                                                 EC:2.7.1.26 EC:2.7.7.2      ribF            Prokka_02136    Core
  FAD_divalent                      Riboflavin synthase                                                                                         EC:2.5.1.9                  ribE            Prokka_02053    Core
  FAD_divalent                      3,4-dihydroxy 2-butanone 4-phosphate synthase / GTP cyclohydrolase II                                       EC:4.1.99.12 EC:3.5.4.25    ribBA           Prokka_02054    Core
  Fumaric acid                      Fumarate reductase, flavoprotein subunit precursor                                                          EC 1.3.99.1                                 Prokka_01381    Core
  Glucose 1-phosphate               Phosphoglucomutase                                                                                          EC 5.4.2.2                  pgmB            Prokka_01441    Core
  Glutathione (GSSG)\_divalent      Glutathione peroxidase                                                                                      EC 1.11.1.9                 gpx             Prokka_00119    Core
  Glutathione (GSSG)\_divalent      Glutathione reductase                                                                                       EC 1.8.1.7                  gor             Prokka_01883    Core
  Glycerol 3-phosphate              2,3-bisphosphoglycerate-dependent phosphoglycerate mutase                                                   EC:5.4.2.11                 PGAM            Prokka_00347    Core
  Glycerol 3-phosphate              2,3-bisphosphoglycerate-dependent phosphoglycerate mutase                                                   EC:5.4.2.12                 PGAM            Prokka_01350    Core
  Glycerol 3-phosphate              Phosphoglycerate kinase                                                                                     EC 2.7.2.3                  pgk             Prokka_01250    Core
  Guanosine                         Purine nucleoside phosphorylase                                                                             EC 2.4.2.1                  deoD            Prokka_01998    Core
  Hydroxyproline                    Pyrroline-5-carboxylate reductase                                                                           EC:1.5.1.2                  proC            Prokka_00530    Core
  Hydroxyproline                    Pyrroline-5-carboxylate reductase                                                                           EC:1.5.1.3                  proC            Prokka_02427    Dispensable
  Inosine                           Adenosine deaminase                                                                                         EC:3.5.4.4                  add             Prokka_01301    Dispensable
  Inosine                           Cytidine deaminase                                                                                          EC:3.5.4.5                  cdd             Prokka_02546    Core
  Malic acid                        malate dehydrogenase                                                                                        EC 1.1.1.38                 maeA            Prokka_01968    Core
  Methionine sulfoxide              Peptide-methionine (R)-S-oxide reductase                                                                    EC:1.8.4.12                 msrB            Prokka_01199    Core
  Methionine sulfoxide              Peptide-methionine (S)-S-oxide reductase                                                                    EC:1.8.4.11                 msrA            Prokka_00761    Core
  Methionine sulfoxide              Peptide-methionine (S)-S-oxide reductase                                                                    EC:1.8.4.12                 msrA            Prokka_02442    Dispensable
  N^8^-Acetylspermidine             diamine N-acetyltransferase                                                                                 EC:2.3.1.57                 speG            Prokka_00195    Dispensable
  N-Acetylglucosamine 1-phosphate   N-acetylglucosamine-1-phosphate uridyltransferase / Glucosamine-1-phosphate N-acetyltransferase             EC 2.7.7.23 /EC 2.3.1.157   glmU            Prokka_00529    Core
  N-Acetylglutamic acid             N-acetylglutamate synthase                                                                                  EC 2.3.1.1                  Nags            Prokka_01559    Core
  N-Acetylneuraminic acid           Phosphoglucosamine mutase                                                                                   EC 5.4.2.10                 glmM            Prokka_01436    Core
  Nicotinamide                      NAD+ kinase                                                                                                 EC 2.7.1.23                 ppnK            Prokka_01377    Core
  Nicotinamide                      NAD+ synthetase                                                                                             EC 6.3.1.5                  nadE            Prokka_02113    Dispensable
  Nicotinamide                      Nicotinate-nucleotide adenylyltransferase                                                                   EC 2.7.7.18                 nadD            Prokka_02109    Core
  Nicotinamide                      N-Ribosylnicotinamide phosphorylase                                                                         EC 2.4.2.1                  deoD            Prokka_01998    Core
  Nicotinamide                      Nicotinate phosphoribosyltransferase                                                                        EC 6.3.4.21                 pncB            Prokka_02111    Core
  Taurine                           Glutamate decarboxylase                                                                                     EC 4.1.1.15                 gadB            Prokka_00031    Dispensable
  Thiamine                          1-deoxy-D-xylulose-5-phosphate synthase                                                                     EC:2.2.1.7                  dxs             Prokka_00257    Dispensable
  Thiamine                          1-deoxy-D-xylulose-5-phosphate synthase                                                                     EC:2.2.1.8                  dxs             Prokka_02507    Dispensable
  Thiamine                          Cysteine desulfurase / selenocysteine lyase                                                                 EC:2.8.1.7                  sufS            Prokka_00426    Core
  Thiamine                          Hydroxyethylthiazole kinase                                                                                 EC:2.7.1.50                 thiM            Prokka_02295    Core
  Thiamine                          Ribosome biogenesis GTPase / thiamine phosphate phosphatase                                                 EC:3.6.1.- 3.1.3.100        rsgA            Prokka_00641    Core
  Thiamine                          Thiaminase (transcriptional activator TenA)                                                                 EC:3.5.99.2                 tenA            Prokka_00414    Core
  Thiamine                          Thiamine-phosphate pyrophosphorylase                                                                        EC:2.5.1.3                  thiE            Prokka_02293    Core
  Thiamine                          tRNA uracil 4-sulfurtransferase                                                                             EC:2.8.1.4                  thiI            Prokka_01389    Core
  Thiamine                          Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase                                                      EC:2.7.1.49 EC:2.7.4.7      thiD            Prokka_02294    Core

*\# Genes were identified based on pan-genome analysis using genome sequence of 20 L. lactis strains including the strain WFLU12 (Nguyen and Kim, [@B51]). The 19 strains include bacteria isolated from dairy product, UL8, C10, UC063, 275, 229, Il1403, 184, KLDS 4.0325, and SO; plant, AI-06, KF147, and NCDO 2118; meat, UC08 and UC11; drain water, IO-01; fermented food, A12; and human, CV56*.

Discussion {#s4}
==========

In this study, concentrations of metabolites measured in the probiotic-fed group were higher overall than those in the control group. In particular, concentrations of 53 and 5 metabolites were significantly higher in intestine and serum samples, respectively, of the probiotic-fed group than those in the control group. However, the number of significantly increased metabolites in the intestine differed somewhat from that in the serum of the probiotic-fed group. Such discrepancy might be due to several gateways from the gut lumen to systemic circulation in the blood. In this study, 45 (category i) metabolites were transported to the blood without being influenced by gateways while 77 (category ii) metabolites influenced by gateways were transported to the blood. Indeed, the types of metabolites that can and cannot be transported to the blood from the lumen remains unclear. A previous study (Matsumoto et al., [@B47]) showed that 11 basic amino acids including Phe, Lys, Ser, Gly, His, Thr, Arg, Pro, and branched chain amino acids (BCAAs) are transported independently from the colon to systemic circulation. In this study, however, most of the basic amino acids (18; see Table [S2](#SM10){ref-type="supplementary-material"}) were found to be filtrated and/or metabolized. This concurs with a previous study (Wu, [@B81]) showing that dietary amino acids can be catabolized by the small intestinal mucosa in the first pass. The intestine can modulate the availability of amino acids to extra-intestinal tissues. For example, the differences between the Pro/Con ratio of Arg (No. 74) and citrulline (No. 44) were observed in the intestinal mucus and serum samples in the present study. Citrulline is mainly synthesized from the conversion of glutamine in the enterocyte. Other amino acids such as arginine, proline, and ornithine can be converted into citrulline, and then released into the blood stream as an important source of endogenous arginine (Curis et al., [@B13]). Therefore, the higher Pro/Con ratio of citrulline in the serum than that in the intestine might be due to the metabolism of the amino acids by enterocytes. Moreover, the gastrointestinal tissue has been demonstrated to possess enzymes needed to metabolize methionine to cysteine (Finkelstein, [@B20]) or perform methionine transmethylation to release homocysteine and cystathionine into the circulation (Townsend et al., [@B76]). In this study, cysteine was only detected in intestinal mucus, and not in the pellet or serum (Additional File [2](#SM13){ref-type="supplementary-material"}), indicating that methionine can be converted to cysteine by gut microbiota and enterocytes, and/or cysteine might be metabolized in the liver before systemic circulation. Cysteine might be extensively metabolized by intestinal enterocytes and the liver via cysteine dioxygenase to form cysteinesulfinate (Malmezat et al., [@B42]), a precursor of taurine. Higher Pro/Con ratio of cystathionine (No. 43) in serum metabolome might indicate transmethylation of methionine in the intestine. Cystathionine in the serum can be an important source of cysteine and glutathione synthesis in the body (Shoveller et al., [@B70]). Therefore, many metabolites might be influenced by intestinal metabolism. Pro/Con ratios of metabolites obtained in the present study are important for understanding the bioavailability of metabolites in fish.

It has been demonstrated that host circulating metabolites are linked to gut microbial species in human. They can cause body weight change by altering host energy harvest and storage (e.g., Wahl et al., [@B78]; Liu et al., [@B40]). Many studies have shown that the dietary supplementation of probiotics in farmed animals including fish can promote their growth without increasing fat mass (Khaksefidi and Rahimi, [@B29]; Šabatková et al., [@B62]). These observations might be due to improved gut function and resistance to infection rather than metabolic imbalance that causes overweight. Rogge ([@B61]) has indicated that overweight is associated with decreased fatty acid β-oxidation. Therefore, overweight individuals are more dependent on the glycolytic pathway for ATP production, resulting in an increase in pyruvate production. The impact of gut microbiome on serum metabolome alterations has also been reported, showing that serum concentrations of many targeted metabolomics profiling of amino acids such as citrulline, cystine, lysine, and leucine are considerably higher in overweight individuals than those in lean controls (Liu et al., [@B40]). In our study, serum concentrations of citrulline, cystathionine (as an intermediate of sulfur amino acid cysteine), 2-hydroxy-4-methylvaleric acid (leucine derivative), and 5-hydroxylysine (an intermediate of lysine; 1.3-fold change; *p* \< 0.1) were considerably higher in the probiotic-fed group of fish than those in the control group (Table [S1](#SM9){ref-type="supplementary-material"}, Additional File [4](#SM15){ref-type="supplementary-material"}). The concentration of allantoic acid in the serum of the probiotic-fed group was also significantly higher compared to that in the control group (1.2-fold change; *p* = 0.05; Table [1](#T1){ref-type="table"} and Additional File [4](#SM15){ref-type="supplementary-material"}). In most fish, the formed allantoin is further degraded to urea and glyoxalate via allantoic acid by allantoicase and allantoinase (Alvarez-Lario and Macarrón-Vivente, [@B1]). Since allantoin can be used for identifying serum uric acid level and predicting weight gain in humans (Masuo et al., [@B45]), increased level of this compound in the serum could be a sign of weight gain in fish.

Metabolites including amino acids are not only major fuels for intestinal mucosa, but also essential precursors for intestinal synthesis of glutathione, nitric oxide, polyamines, purine, and pyrimidine nucleotides as well as amino acids (e.g., citrulline, cysteine) which in turn will maintain intestinal mucosal mass and integrity (Wu, [@B81]). In this study, concentrations of citrulline in both the intestine and serum of probiotic-fed fish were significantly higher than those in the control. In general, arginine has a very weak gastrointestinal uptake rate. However, citrulline can be easily taken up in the gut and then converted to arginine in the kidney (Dhanakoti et al., [@B17]; Curis et al., [@B13]). The gut is known as the primary organ responsible for most circulating citrulline synthesis from glutamine (with ornithine carbamoyltransferase) (Wu, [@B81]; Bolotin et al., [@B7]). However, de novo synthesis of arginine in fish is limited or completely absent due to the lack of pyrroline-5-carboxylate (P5C) synthase in fish (Li et al., [@B39]). P5C is the key enzyme involved in the synthesis of proline and ornithine from glutamine/glutamate. These intermediates are then further metabolized to citrulline and arginine (Li et al., [@B39]). Therefore, fish have particularly high requirements for dietary arginine as a nutritionally indispensable and essential amino acid for growth. Kao et al. ([@B28]) have shown that the unique gut microbiota might contribute to altered arginine and citrulline metabolism. It is well known that arginine is converted to citrulline through arginine deiminase (ADI) pathway (Noens et al., [@B53]). Similar to other *L. lactis* strains such as strain IL-1403 (Bolotin et al., [@B7]) and ATCC 7962 (Kim et al., [@B31]), strain WFLU12 harbors biosynthetic genes involved in the ADI pathway (Table [2](#T2){ref-type="table"}). It has been demonstrated that the ADI pathway of *L. lactis* is a biocatalyst for citrulline production with a very high specific activity (140.3 U/mg) (Kim et al., [@B31]; Song et al., [@B73]).

Concentrations of polyamine (N8-acetylspermidine) and creatine in probiotics-fed fish were significantly higher than those in the control group (Table [1](#T1){ref-type="table"}). This might be due to sufficient production of citrulline. Arginine derived from a precursor of citrulline can be catabolized to intermediates such as ornithine and guanidinoacetic acid (Figure [S4](#SM4){ref-type="supplementary-material"}), yielding polyamine and creatine as previously described (Morris, [@B49]; Andersen et al., [@B3]). Creatine is used as a storage molecule for energy in the form of phosphocreatine in the muscle. It has potential to increase muscle mass (Andersen et al., [@B3]). Creatine metabolism plays an essential role in epithelial cell barrier function and intestinal homeostasis in mice (Turer et al., [@B77]). Polyamines and their acetylated derivatives are essential in regulating and renewing intestinal mucosa (Gao et al., [@B22]; Ramani et al., [@B60]). Péres et al. ([@B58]) have demonstrated that dietary polyamine spermine can increase digestive enzyme activity and promote intestinal maturation in sea bass larvae (*Dicentrarchus labrax*). Taken together, these results suggest that increased turnover of polyamine and creatine might be related to the increase of citrulline in probiotic-fed fish, implying its potential effects on energy metabolism and maintenance of robust gut health (Andersen et al., [@B2]) as well as symbiotic probiotics--host metabolic interactions.

It has been demonstrated that dietary supplementation with nucleotides (e.g., inosine, guanosine) can enhance the growth performance of many fish species, including olive flounder (Burrells et al., [@B9]; Song et al., [@B72]). Nucleotides might be very important for improving intestinal morphology (Cheng et al., [@B10]; Peng et al., [@B57]) because intestinal cells lack the ability to de novo synthesize nucleotides and must depend on exogenous supply (Quan, [@B59]). In the present study, purine derivatives including inosine, hypoxanthine, AMP, and guanosine were increased in the probiotic-fed group (Table [1](#T1){ref-type="table"}, Figure [S5](#SM5){ref-type="supplementary-material"}), indicating that dietary supplementation of strain WFLU12 could induce de novo synthesis of purines in the intestine to meet the requirement for growth. Strain WFLU12 possesses gene *add* encoding adenosine deaminase (EC 3.5.4.4, Table [2](#T2){ref-type="table"}). This gene can convert adenosine to inosine for utilizing general purine sources (Martinussen et al., [@B44]; Kilstrup et al., [@B30]).

In this study, concentrations of taurine and its precursors such as cysteic acid, homocysteic acid, and cysteinesulfinic acid were found to be significantly increased in the intestine of the probiotic-fed group compared to those in the control (Table [1](#T1){ref-type="table"}; Figure [S6](#SM6){ref-type="supplementary-material"}). Taurine is a sulfonic acid found in high concentrations in animal tissues, including olive flounder (Sakaguchi and Murata, [@B64]; Jang et al., [@B26]). In recent years, several studies have demonstrated the essentiality (i.e., improved growth and survival) of dietary taurine for many commercially relevant species, especially marine teleosts including olive flounder (Park et al., [@B56]; Kim et al., [@B34], [@B33]; Salze and Davis, [@B65]). Previous studies (Park et al., [@B56]; Wang et al., [@B79]) have demonstrated that olive flounder has a very weak taurine biosynthetic capability due to a mutation in enzyme cysteic acid decarboxylase (CAD). In the present study, KEGG analysis of *L. lactis* genome showed that it possessed genes encoding enzymes that might be involved in the biosynthesis of cysteic acid (Table 2) via serine/sulfate pathway (Machlin et al., [@B41]; Tevatia et al., [@B74]). Gene *gad*B (EC 4.1.1.15) encoding glutamate decarboxylase beta can potentially decarboxylate cysteic acid to yield taurine. In this study, analysis of molecular dynamics simulations and homology modeling for GAD protein of *L. lactis* WFLU12 and its substrates showed that both CSA and CA simulation shared binding sites of pyridoxal-5′-phosphate in GAD of the *L. lactis* structural model (Figure [S7](#SM7){ref-type="supplementary-material"}, Supplementary Material). Thus, GAD of *L. lactis* might be potentially involved in the bio-conversion of taurine and dietary supplementation of *L. lactis* might have contributed to the completion of the biosynthetic pathway of taurine in fish intestine.

It is worth noting that concentrations the 3-hydroxybutyric acid (3HBA) and 2-hydroxy-4-methylvaleric acid (HICA) values were significantly higher in the probiotic-fed group than those in the control group (Table [1](#T1){ref-type="table"}). 3HBA is a storage compound of short chain fatty acids (SCFA) acetate (García Martín et al., [@B23]; Yagci et al., [@B83]) derived from fermentation of dietary fibers by intestinal microbiota (den Besten et al., [@B16],[@B15]). Amino acid derivative HICA is a protein-fermentation product of bacteria such as lactobacilli (Smit et al., [@B71]). The increase of 3HBA was correlated with increased acetoacetic acid (also diacetate) in the serum (Additional File [4](#SM15){ref-type="supplementary-material"}), indicating that these ketone bodies might be readily reconverted to acetyl-CoA to produce energy (Laffel, [@B35]). Hence, metabolic shift of SCFA in the gut of fish can beneficially aid in nutrition source and ATP production for cells lining the intestine (den Besten et al., [@B15]; Jost et al., [@B27]). It has been revealed that HICA can increase weight and muscle mass in chickens and rats (Boebel and Baker, [@B6]). In the present study, genes encoding enzyme 3-hydroxyisobutyrate dehydrogenase for conversion of 3HBA to acetoacetic acid and L-2-hydroxyisocaproate dehydrogenase (HicDH) for HICA production (de Cadiñanos de et al., [@B14]) were found in our probiotic genome (Table [2](#T2){ref-type="table"}). However, functions of these metabolites in fish are not yet fully understood. Thus, further study is needed to clarify their functions in fish.

Concentrations of several metabolites involved in the TCA cycle were increased significantly in the intestine of fish fed with probiotics (Figure [S8](#SM8){ref-type="supplementary-material"}). TCA cycle intermediates are known to be able to improve growth, nutrients absorption, and bioavailability of minerals in several fish species (e.g., Pan et al., [@B55]; Sarker et al., [@B66]). In addition, increased carnitine, a key metabolite involved in fatty acid catabolism by β-oxidation after esterification to release stored energy from fatty acid (Xie et al., [@B82]) in the intestine of probiotic-fed group (Table [1](#T1){ref-type="table"}), might be related to improvement of fat digestibility, thus increasing citric acid production through AcCoA intermediate (Figure [S7](#SM7){ref-type="supplementary-material"}). Digesting and absorbing dietary nutrients are critical physiological functions of the intestine necessary for maximal growth of the organism. In this context, the intestine has a high rate of energy expenditure because digestion and absorption processes are critically dependent on energy (Yang et al., [@B84]). Results of the present study suggest that energy generated from the citric acid cycle in the intestine might benefit fish digestion and absorption of nutrients in the probiotic-fed group, thus contributing to significant growth improvement.

Vitamins are important organic compounds that are essential for optimal growth and the health of animals. In general, vitamins are not synthesized by fish. They need to be supplied in the diet (Craig and Helfrich, [@B12]). It is well known that intestinal bacteria as well as lactic acid bacteria can synthesize and supply various vitamins (LeBlanc et al., [@B38]). In the present study, we found that fish in the probiotic-fed group showed increased levels of vitamin C (Table [1](#T1){ref-type="table"}), known to be related to improvement of growth performance and feed utilization in different fish species (Fournier et al., [@B21]; Kim and Kang, [@B32]). In this study, increased level of hydroxyproline in the probiotic-fed group might be related to post-translational hydroxylation of proline by vitamin C-dependent prolyl hydroxylase (Li et al., [@B39]). Members of vitamin B complex are also needed in fish diet as they play major roles in growth, physiology, and cellular metabolism (Shiau and Lin, [@B68]). In this study, levels of co-enzymes such as riboflavin, thiamine, and nicotinamide were increased in fish fed with probiotics compared to those in the control group (Table [1](#T1){ref-type="table"}), indicating that they might play an important role in energy metabolism of carbohydrates, fats, and proteins (LeBlanc et al., [@B37]). Similar to other *L. lactis* strains (Burgess et al., [@B8]; Shimizu-Kadota et al., [@B69]), our strain possesses various genes involved in the bioconversion of vitamins (Table [2](#T2){ref-type="table"}). These features of strain WFLU12 might confer fish metabolic versatility of converting materials for energy in fish intestine.

Previous studies (e.g., Drissi et al., [@B19]) on weight gain-associated *Lactobacillus* spp. have shown that these *Lactobacillus* encode ubiquitous enzymes with key roles in β-oxidation pathway of fatty acid degradation (Thiolase I; EC 2.3.1.16) and various biosynthetic pathways (Thiolase II; EC 2.3.1.9) such as poly β-hydroxybutyric acid synthesis and steroid biogenesis (Haapalainen et al., [@B24]). Thus, genomes of weight gain-associated *Lactobacillus* might be able to mobilize energy and carbon stored in fatty acids through β-oxidation. In agreement with this, our strain harbored both thiolase I and II (Table [2](#T2){ref-type="table"}). These might be responsible for the increase of poly β-hydroxybutyric acid and β-oxidation pathway (level of carnitine in Table [1](#T1){ref-type="table"}). This is another evidence supporting that our probiotic strain could increase different kinds of metabolites as observed in this study.

Conclusion {#s5}
==========

Dietary supplementation with *L. lactis* WFLU12 greatly influenced metabolism in fish. Several metabolites including citrulline, TCA cycle intermediates, SCFA, vitamins, and taurine are likely to be linked to growth promotion in fish. In particular, our probiotic strain has a number of genes encoding diverse enzymes to help many important metabolic pathways such as urea cycle relating metabolism, taurine biosynthesis, and de novo synthesis of nucleotides in the intestine. In the field of gastrointestinal physiology, our pioneering study demonstrates that intestinal catabolism plays a very important role in modulating metabolite availability to extra-intestinal tissues. Our data also provide novel insights into the metabolomic mode of action of probiotics involved in fish health and growth.
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Classification of intestinal metabolites in four different groups displayed in Figure [4A](#F4){ref-type="fig"}. Identified metabolites were classified into 10 functional groups (see main text for details).
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Click here for additional data file.

###### 

Ratio of metabolite concentration in probiotic-fed vs. control. **(A)** Intestinal metabolites. **(B)** Serum metabolites. The ratio is computed by using averaged detection values.
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Click here for additional data file.

###### 

Differences of serum metabolites between control fish and probiotic-fed fish on systemic metabolic pathways. Relative quantities of annotated metabolites are presented as bar graphs (green, control; orange, probiotic). Metabolites surrounded by red circles are of higher concentrations in the probiotic group than those in the control group. ND, not detected.
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###### 

Differences of intestinal metabolites between control fish and probiotic-fed fish on urea cycle related metabolism pathways. Relative areas of annotated metabolites are presented as bar graphs (blue, control; red, probiotic). Metabolites surrounded by red circles are of higher concentrations in the probiotic group than those in the control group. ND, not detected.
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###### 

Differences of intestinal metabolites between control and probiotic fish on purine metabolism pathways. Relative quantities of annotated metabolites are presented as bar graphs (blue, control; red, probiotic). Metabolites surrounded by red circles are of higher concentrations in the probiotic group than those in the control group. ND, not detected.
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###### 

Differences of intestinal metabolites between control fish and probiotic-fed fish on lipid and amino acid metabolism pathways. Relative areas of annotated metabolites are presented as bar graphs (blue, control; red, probiotic). Metabolites surrounded by red circles are of higher concentrations in the probiotic group than those in the control group. ND, not detected.
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###### 

Binding sites of pyridoxal-5′-phosphate (PLP) and substrates in *L. lactis* GAD. The overall dimeric structure of LcGAD is indicated by ribbons and colored by blue and red for each chain (A). PLP and substrates (B: L-Glu, C: CSA, D: CA) are presented as thick sticks and residues forming the binding site are presented as thin sticks. Carbon, nitrogen, oxygen, phosphorus, and sulfur atoms are colored by cyan, blue, red, gold, and yellow, respectively.
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###### 

Differences of intestinal metabolites between control fish and probiotic-fed fish on the central carbon metabolism pathways. Relative areas of annotated metabolites are presented as bar graphs (blue, control; red, probiotic). Metabolites surrounded by red circles are of higher concentrations in the probiotic group than those in the control group. ND, not detected.
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List of metabolites significantly changed in the serum. 1\<, only detected in probiotic group. N.D. (Not Detected): Target peak or metabolite was below detection limits.
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Pro/Con ratio and possible influence of gateways on each metabolite detected in the intestine and serum.
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Binding sites of PLP and substrates in three simulation systems.
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Compounds detected in the pellet mixed with probiotics (Pellet-P) and control pellet (Pellet-C).
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List of 147 metabolites in group IFP ≈ IFC.
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List of 53 intestinal metabolites increased significantly in probiotic-fed fish (group IFP \> IFC).
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List of 160 metabolites showing no significant change in the serum.
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Additional information on metabolite classification (Figure [4](#F4){ref-type="fig"}).
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